“…For example, ASF/SF2, SC35 and SRp38, which are all efficiently targeted by SRPK1 (Xiao and Manley, 1997;Shi and Manley, 2007), have been shown to regulate alternative splicing of glutamate receptor subunit 2 (GluR2) in the nervous system. Co-expression of ASF/SF2 and SC35 in neurons increases the flop to flip splice ratio of GluR2 (Crovato and Egebjerg, 2005), while phosphorylated SRp38 promotes the inclusion of flip exon in GluR2 pre-mRNA splicing (Feng et al, 2008). Furthermore, SRPK1, through the phosphorylation of a variety of SR proteins, has been previously reported to regulate the alternative splicing of tau protein and in particular exon 10 splicing, which has been involved in the pathogenesis mainly of Frontotemporal Dementia and to a lesser extent in other tauopathies, such as Alzheimer disease (Hartmann et al, 2001;Andreadis, 2011, and references therein).…”